Pacific Biosciences Stock Forward View - 4 Period Moving Average
| PACB Stock | USD 1.41 -0.24 -14.55% |
Pacific Biosciences of's 4 Period Moving Average forecast is generated from the selected price series and evaluated against observed values. Forecast accuracy depends on how stable the recent price trend has been — trending markets suit some models better than others. The forecast is recalculated with each session so it does not rely on stale inputs. A small Bias confirms the model is not systematically over- or under-predicting. The 4 Period Moving Average model projects Pacific Biosciences at 1.54 for the next trading day, above the most recent closing price. All values shown are model-generated projections and should be evaluated alongside other analytical inputs.
4 Period Moving Average Price Forecast For the 11th of May 2026
Over a 90-day horizon, the 4 Period Moving Average model forecasts Pacific Biosciences at 1.54 for the next trading day, with a mean absolute deviation of 0.07 , mean absolute percentage error of 0.05 , and sum of absolute errors of 4.24 .This represents a tight forecast with good short-term tracking of Pacific Biosciences' price movement. This output is intended for short-term analytical reference.
Stock Forecast Pattern
| Backtest Pacific Biosciences | Pacific Biosciences Price Prediction | Research Analysis |
Forecasted Value
The next-day forecast range for Pacific Biosciences defines statistically derived downside and upside boundaries based on model performance. The current forecast range spans downside near 0.01 and upside near 6.34. The wide range indicates elevated uncertainty in short-term projections.
Model Predictive Factors
The table below summarizes the 4 Period Moving Average model's error metrics for Pacific Biosciences stock. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.| AIC | Akaike Information Criteria | 105.9761 |
| Bias | Arithmetic mean of the errors | 0.0072 |
| MAD | Mean absolute deviation | 0.0744 |
| MAPE | Mean absolute percentage error | 0.05 |
| SAE | Sum of the absolute errors | 4.24 |
Other Forecasting Options for Pacific Biosciences
Bollinger Bands applied to Pacific Stock price data measure how far Pacific has deviated from its recent average relative to its own volatility. This distinction drives the choice of forecasting model applied to Pacific Biosciences' price data. On-balance volume for Pacific Stock creates a running indicator of buying versus selling pressure in Pacific. Price departures from the channel boundary often mean-revert, offering tactical signals for Pacific Biosciences'.Pacific Biosciences Related Equities
These related stocks within the Health Care space give benchmarks for judging Pacific Biosciences' results, margins, and growth trend. Revenue and margin checks across this group help investors set expectations for Pacific Biosciences' results.
| Risk & Return | Correlation |
Pacific Biosciences Market Strength Events
Market strength indicators for Pacific Biosciences quantify how the stock responds to shifts in volume and sentiment. These indicators capture shifts in momentum that may precede significant price moves in Pacific Biosciences. The Market Facilitation Index measures how efficiently price moves relative to volume — rising MFI with rising volume signals strong trend participation. Monitoring these indicators for Pacific Biosciences through complete market cycles reveals recurring patterns.
Pacific Biosciences Risk Indicators
Analyzing Pacific Biosciences' risk indicators separates symmetric price swings from asymmetric downside exposure. Understanding and quantifying the risks present in Pacific Biosciences helps place recent price behavior in context. These metrics are most informative when compared against similar equities with comparable growth profiles and market capitalization. When semi-deviation is high relative to standard deviation, Pacific Biosciences' losses have been disproportionately large compared to gains.
| Mean Deviation | 3.87 | |||
| Standard Deviation | 4.99 | |||
| Variance | 24.89 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pacific Biosciences Short Properties
Short sentiment tied to Pacific Biosciences of matters because heavier bearish pressure can change how quickly future price expectations become unstable. This is applicable when the question is whether bearish pressure is starting to shape the market's reaction function.
| Common Stock Shares Outstanding | 299.96 million | |
| Cash And Short Term Investments | 279.51 million |